Company News

14 02, 2023

mRNA Analytical Development Summit – 2023

2025-06-24T14:26:29+00:00

With several years of experience supporting a world-renowned mRNA COVID-19 vaccine company with raw material and drug substance release, Avance Biosciences™ is well-positioned to provide industry-leading assay design, validation, and sample testing services that advance our clients’ mRNA therapeutic...

mRNA Analytical Development Summit – 20232025-06-24T14:26:29+00:00
28 11, 2022

Gene Therapy Analytical Development Summit – 2022

2025-06-24T14:26:29+00:00

Avance offers a broad range of assay development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support IND-enabling and clinical studies. With decades of experience helping gene and cell therapy companies, Avance Biosciences™ has the...

Gene Therapy Analytical Development Summit – 20222025-06-24T14:26:29+00:00
22 11, 2022

Quantification of On/Off-Target Gene Editing

2025-06-24T14:35:30+00:00

Quantitative analysis of gene editing is now an essential step in getting regulatory approval of gene editing-based therapies. But designing and validating assays for on/off-target editing analysis and building an internal team to perform them can be costly and inefficient...

Quantification of On/Off-Target Gene Editing2025-06-24T14:35:30+00:00
11 10, 2022

Cell & Gene Meeting on the Mesa – 2022

2025-06-24T14:26:29+00:00

Avance offers a broad range of assay development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support IND-enabling and clinical studies. With decades of experience helping gene and cell therapy companies, Avance Biosciences™ has the...

Cell & Gene Meeting on the Mesa – 20222025-06-24T14:26:29+00:00
27 09, 2022

Biotech Boston – 2022

2025-06-24T14:26:29+00:00

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

Biotech Boston – 20222025-06-24T14:26:29+00:00
16 02, 2021

Avance Biosciences™ Expanding Houston Campus

2025-06-24T13:36:38+00:00

HOUSTON, Feb. 16, 2021 /PRNewswire/ -- Avance Biosciences™, a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services supporting biological drug development and manufacturing, announced today that its Houston facility, which successfully passed an inspection by the U.S. Food and Drug Administration in Oct 2018, is undergoing major expansion to handle rapidly growing demand for their services. [...]

Avance Biosciences™ Expanding Houston Campus2025-06-24T13:36:38+00:00
7 12, 2020

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company

2025-06-24T14:38:01+00:00

Pharm Tech Outlook, a highly respected pharmaceutical/biotech industry magazine, has recognized Avance Biosciences™ as a top 10 Genomics Solutions Company for 2020. Genomic technologies and their usage have seen extensive growth in the past decade. Over the years, these technologies have evolved significantly and can now be used [...]

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company2025-06-24T14:38:01+00:00
19 06, 2019

Phage Testing of Bacterial Cultures

2025-06-24T13:30:28+00:00

Regulatory agencies require companies using microbial cell lines that produce products for human use to regularly complete biosafety testing to ensure that cell banks are free of phage contamination. Bacteriophage (phage) is a virus that infects and replicates within bacteria1, basically bacterial predators. One hundred times smaller than a bacterium, phage are found wherever [...]

Phage Testing of Bacterial Cultures2025-06-24T13:30:28+00:00
11 06, 2019

NGS for Biologics Development Support

2025-06-24T13:32:03+00:00

NGS represents a technological leap that has potential to revolutionize drug discovery and development. Next Generation Sequencing (NGS) has the potential to unlock causative factors from our genetic material. NGS also represents a technological advancement using array-based sequencing that will improve many aspects of scientific research and advance the field of personalized medicine. Because [...]

NGS for Biologics Development Support2025-06-24T13:32:03+00:00
30 10, 2018

Avance Biosciences™ Completes Successful FDA Inspection

2025-07-17T19:08:45+00:00

HOUSTON, Oct. 30, 2018 - Avance Biosciences™, Inc., a leading biological testing company supporting drug development and manufacturing, announced today that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018.  This inspection focused on the firm’s quality management system, operation procedures, and data integrity, as [...]

Avance Biosciences™ Completes Successful FDA Inspection2025-07-17T19:08:45+00:00
Go to Top